Literature DB >> 21780275

The use of gadolinium in patients with contrast allergy or renal failure requiring coronary angiography, coronary intervention, or vascular procedure.

Layth Saleh1, Elizabeth Juneman, Mohammad Reza Movahed.   

Abstract

Coronary artery angiography remains an important procedure for the assessment of coronary arteries. It requires injection of iodinated contrast for the opacification of coronary arteries. Severe allergy to iodine contrast and renal insufficiency are two main problems with iodine-based contrast media. Gadolinium (Gd) has different chemical structure with no cross reactivity with iodine-based contrast media in patients with iodine allergy. The use of Gd is commonly used in contrast-enhanced magnetic resonance imaging for image enhancement, making it a potential alternative in patients in whom iodine is contraindicated. The aim of this manuscript is to review the available literature on the use of Gd in patients with contraindication to iodine contrast due to allergy or in patients with severe renal failure requiring coronary or vascular procedures.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21780275     DOI: 10.1002/ccd.22907

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  11 in total

Review 1.  Overview of left ventricular outpouchings on cardiac magnetic resonance imaging.

Authors:  Arun Sharma; Sanjeev Kumar
Journal:  Cardiovasc Diagn Ther       Date:  2015-12

2.  Robust pCASL perfusion imaging using a 3D Cartesian acquisition with spiral profile reordering (CASPR).

Authors:  Joshua S Greer; Xinzeng Wang; Yiming Wang; Marco C Pinho; Joseph A Maldjian; Ivan Pedrosa; Ananth J Madhuranthakam
Journal:  Magn Reson Med       Date:  2019-06-23       Impact factor: 4.668

3.  Nephrotoxicity of gadolinium-based contrast in the setting of renal artery intervention: retrospective analysis with 10-year follow-up.

Authors:  Edwin A Takahashi; David F Kallmes; Kristin C Mara; William S Harmsen; Sanjay Misra
Journal:  Diagn Interv Radiol       Date:  2018-11       Impact factor: 2.630

4.  Coronary physiology and percutaneous intervention managed with gadolinium road mapping and intravascular ultrasound in hyperthyroidism.

Authors:  Peter Tajti; Mohamed Ayoub; Thomas Nuehrenberg; Kambis Mashayekhi
Journal:  Cardiol J       Date:  2021-03-01       Impact factor: 2.737

Review 5.  Quantitative Methods in Abdominal MRI: Perfusion Imaging.

Authors:  Ananth J Madhuranthakam; Qing Yuan; Ivan Pedrosa
Journal:  Top Magn Reson Imaging       Date:  2017-12

6.  Severe liver and renal injuries following cerebral angiography: late life-threatening complications of non-ionic contrast medium administration.

Authors:  Paulo Sergio Lucas da Silva; Emerson Yukio Kubo; Marcelo Cunio Machado Fonseca
Journal:  Childs Nerv Syst       Date:  2015-08-19       Impact factor: 1.475

7.  Zero-iodinated contrast retrograde percutaneous coronary interventions of chronic total occlusions using gadolinium and imaging guidance: a case report of a patient with severe anaphylaxis to iodinated contrast.

Authors:  Ankur Gupta; Saroj Neupane; Mir Basir; Khaldoon Alaswad
Journal:  Eur Heart J Case Rep       Date:  2020-05-03

Review 8.  Assessment of immediate and non-immediate hypersensitivity contrast reactions by skin tests and provocation tests: A review.

Authors:  Rakesh D Bansie; A Faiz Karim; Maurits S van Maaren; Maud Aw Hermans; Paul LA van Daele; Roy Gerth van Wijk; Saskia M Rombach
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

Review 9.  Contrast-induced Nephropathy.

Authors:  Nazar M A Mohammed; Ahmed Mahfouz; Katafan Achkar; Ihsan M Rafie; Rachel Hajar
Journal:  Heart Views       Date:  2013-07

10.  Intrasession Reliability of Arterial Spin-Labeled MRI-Measured Noncontrast Perfusion in Glioblastoma at 3 T.

Authors:  Limin Zhou; Yiming Wang; Marco C Pinho; Edward Pan; Yin Xi; Joseph A Maldjian; Ananth J Madhuranthakam
Journal:  Tomography       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.